Price
$1.65
Decreased by -1.56%
Dollar volume (20D)
28.10 K
ADR%
7.52
Earnings report date
May 12, 2025
Shares float
3.44 M
Shares short
60.37 K [1.75%]
Shares outstanding
5.53 M
Market cap
9.67 M
Beta
1.64
Price/earnings
N/A
20D range
1.41 1.99
50D range
1.41 2.79
200D range
1.41 5.01

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications.

The company is headquartered in Doylestown, Pennsylvania.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 24, 25 -0.49
Increased by +46.74%
-0.54
Increased by +9.26%
Nov 7, 24 -0.64
Increased by +25.58%
-0.74
Increased by +13.51%
Aug 12, 24 -0.58
Increased by +33.33%
-0.63
Increased by +7.94%
May 14, 24 -0.67
Increased by +50.00%
-0.78
Increased by +14.10%
Mar 26, 24 -0.92
Increased by 0.00%
-0.77
Decreased by -19.48%
Nov 9, 23 -0.86
Increased by +64.17%
-1.16
Increased by +25.86%
Aug 10, 23 -0.87
Increased by +95.56%
-1.42
Increased by +38.73%
May 15, 23 -1.34
Increased by +81.39%
-1.50
Increased by +10.67%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by -100.00%
-2.89 M
Increased by +15.93%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by -100.00%
-3.78 M
Decreased by -18.08%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 561.57 K
Increased by +124.91%
-3.47 M
Decreased by -6.47%
Decreased by -617.92%
Increased by +52.66%
Mar 31, 24 380.57 K
Increased by +N/A%
-2.81 M
Increased by +32.30%
Decreased by -738.39%
Decreased by N/A%
Dec 31, 23 14.07 K
Increased by +N/A%
-3.44 M
Increased by +96.89%
Decreased by -24.46 K%
Decreased by N/A%
Sep 30, 23 319.47 K
Increased by +N/A%
-3.20 M
Increased by +23.26%
Decreased by -1.00 K%
Decreased by N/A%
Jun 30, 23 249.69 K
Increased by +N/A%
-3.26 M
Increased by +96.68%
Decreased by -1.31 K%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-4.15 M
Increased by +47.72%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY